Last reviewed · How we verify
NCT04206917
MultiPulse Therapy (MPT) for AF
NA trial testing Multi Pulse Therapy in Atrial Fibrillation, Paroxysmal in 30 participants. Terminated before completion.
21 June 2022
Quick facts
| Lead sponsor | Cardialen, Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 30 |
| Start date | 19 March 2020 |
| Primary completion | 21 June 2022 |
| Estimated completion | 21 June 2022 |
| Sites | 6 locations across Australia |
Drugs / interventions tested
- Multi Pulse Therapy
Conditions studied
- Atrial Fibrillation, Paroxysmal — all drugs for Atrial Fibrillation, Paroxysmal →
- Atrial Fibrillation, Persistent — all drugs for Atrial Fibrillation, Persistent →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Cardialen, Inc.
Who can join
Adults 18 to 80, any sex, with Atrial Fibrillation, Paroxysmal or Atrial Fibrillation, Persistent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assess the clinical safety and feasibility of MultiPulse Therapy (MPT) electrical stimulation waveform sequence in terminating paroxysmal and persistent atrial fibrillation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04206917
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cardialen, Inc. trials
Trials by the same sponsor.
- NCT05055921 — MultiPulse Therapy (MPT) for AF (US) · NA · terminated
- NCT04939584 — Patient Perception of MultiPulse Therapy™ (MPT™) · NA · terminated
- NCT03871231 — Unpinning Termination Therapy for VT/VF · NA · terminated
- NCT03093051 — Unpinning Termination Therapy for VT (US) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04206917 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardialen, Inc.
- Last refreshed: 14 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04206917.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing